×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Journey Medical Corp. (DERM) NASDAQ

$5.18 (0.29) (-5.30%)

Market Cap: $72.59M

As of 06/21/24 04:00 PM EDT. Market closed.

(DERM)

Journey Medical Corp. (DERM)
NASDAQ

$5.18
(0.29) (-5.30%)

Market Cap: $72.59M

As of 06/21/24 04:00 PM EDT. Market closed.

Add to Portfolio
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO Compensation (Base)
$572,500
CEO Compensation (Total)
$4.37M
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO Compensation (Base)
$572,500
CEO Compensation (Total)
$4.37M
URL
Address
.
PRICE CHART FOR JOURNEY MEDICAL CORP
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$5.46
Previous Close
$5.47
Days Range
$5.18 - $5.59
52 week range
$1.52 - $8.11
Volume
121,303
Avg. Volume (30 days)
133,014
Market Cap
$72.59M
Dividend Yield
-
P/E
(17.45)
Shares Outstanding
14,012,896
Open
$5.46
Previous Close
$5.47
Days Range
$5.18 - $5.59
52 week range
$1.52 - $8.11
Volume
121,303
Avg. Volume (30 days)
133,014
Market Cap
$72.59M
Dividend Yield
-
P/E
(17.45)
Shares Outstanding
14,012,896
FINANCIAL STATEMENTS FOR JOURNEY MEDICAL CORP
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR JOURNEY MEDICAL CORP
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
ROSENWALD LINDSAY A MDDirectorMar 25, 2024 Buy$3.0410,00030,400144,245Mar 27, 2024, 07:00 AM
Maraoui ClaudePresident & CEOMar 22, 2024 Buy$3.4810,00034,7902,163,430Mar 25, 2024, 04:03 PM
Smith Justin AdamDirectorMar 22, 2024 Buy$3.4730,000104,100134,717Mar 25, 2024, 04:02 PM
ROSENWALD LINDSAY A MDDirectorMar 22, 2024 Buy$3.4020,00068,000134,245Mar 25, 2024, 04:01 PM
Benesch JosephInterim CFOFeb 22, 2024 Sale$3.752,4509,18860,710Feb 23, 2024, 05:54 PM
Paley JeffreyDirectorNov 08, 2023 Sale$3.76255959114,217Dec 08, 2023, 05:01 PM
Paley JeffreyDirectorNov 07, 2023 Sale$3.482,2457,813114,472Dec 08, 2023, 05:01 PM
Paley JeffreyDirectorNov 28, 2023 Sale$5.221,7459,10970,727Nov 29, 2023, 04:42 PM
Smith Justin AdamDirectorOct 13, 2023 Buy$2.9833,00098,340104,717Oct 17, 2023, 04:01 PM
Paley JeffreyDirectorOct 06, 2023 Buy$2.9815,00044,70072,472Oct 10, 2023, 04:41 PM
Paley JeffreyDirectorSep 21, 2023 Buy$2.9730,00089,10057,472Sep 25, 2023, 04:01 PM
Maraoui ClaudePresident & CEOSep 06, 2023 Buy$2.5226,04465,6312,153,430Sep 08, 2023, 01:26 PM
ROSENWALD LINDSAY A MDDirectorSep 06, 2023 Buy$2.23100,000223,000114,245Sep 08, 2023, 01:25 PM
Maraoui ClaudePresident & CEOJul 24, 2023 Sale$1.7620,76736,5502,127,386Jul 25, 2023, 04:05 PM
Benesch JosephSee RemarksJul 24, 2023 Sale$1.764,0727,16763,160Jul 25, 2023, 04:05 PM
Maraoui ClaudePresident & CEOMay 17, 2023 Sale$1.3424,37732,6652,148,153May 18, 2023, 04:31 PM
Maraoui ClaudePresident & CEOMay 16, 2023 Sale$1.2520,00025,0002,172,530May 18, 2023, 04:31 PM
De Paolantonio Ernest RobertSee RemarksOct 04, 2022 Sale$2.4110,09324,324259,907Mar 01, 2023, 09:46 PM
Benesch JosephInterim CFOFeb 22, 2023 Sale$1.972,7685,45367,232Feb 23, 2023, 05:01 PM
De Paolantonio Ernest RobertChief Financial OfficerOct 04, 2022 Sale$2.4110,09324,324259,907Oct 06, 2022, 04:30 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
ROSENWALD LINDSAY A MDDirector03/25/202430,400
Maraoui ClaudePresident & CEO03/22/202434,790
Smith Justin AdamDirector03/22/2024104,100
ROSENWALD LINDSAY A MDDirector03/22/202468,000
Benesch JosephInterim CFO02/22/20249,188
Paley JeffreyDirector11/08/2023959
Paley JeffreyDirector11/07/20237,813
Paley JeffreyDirector11/28/20239,109
Smith Justin AdamDirector10/13/202398,340
Paley JeffreyDirector10/06/202344,700
Paley JeffreyDirector09/21/202389,100
Maraoui ClaudePresident & CEO09/06/202365,631
ROSENWALD LINDSAY A MDDirector09/06/2023223,000
Maraoui ClaudePresident & CEO07/24/202336,550
Benesch JosephSee Remarks07/24/20237,167
Maraoui ClaudePresident & CEO05/17/202332,665
Maraoui ClaudePresident & CEO05/16/202325,000
De Paolantonio Ernest RobertSee Remarks10/04/202224,324
Benesch JosephInterim CFO02/22/20235,453
De Paolantonio Ernest RobertChief Financial Officer10/04/202224,324
Load More Insider Transactions
FUNDS WITH A POSITION IN JOURNEY MEDICAL CORP
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
RENAISSANCE TECHNOLOGIES LLC270,6000.00157%3.68%Other
GEODE CAPITAL MANAGEMENT, LLC89,0750.00003%3.84%Other
BLACKROCK INC.49,4090%12.57%Other
ROYCE & ASSOCIATES LP12,6540.00042%NewValue
CHANGE IN SHARES OUTSTANDING FOR JOURNEY MEDICAL CORP
STOCK BUYBACKS FOR JOURNEY MEDICAL CORP
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
06/30/2023
3.83%
2Q
12/31/2023
03/31/2023
4.98%
3Q
12/31/2023
12/31/2022
5.43%
4Q
12/31/2023
09/30/2022
6.11%
5Q
12/31/2023
06/30/2022
7.09%
6Q
12/31/2023
03/31/2022
7.95%
7Q
12/31/2023
12/31/2021
83.46%
8Q
12/31/2023
03/31/2021
71.55%
11Q
12/31/2023
12/31/2020
71.64%
12Q
12/31/2023
09/30/2020
73.09%
13Q
12/31/2023
06/30/2020
72.57%
14Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
3.83%
2Q
03/31/2023
4.98%
3Q
12/31/2022
5.43%
4Q
09/30/2022
6.11%
5Q
06/30/2022
7.09%
6Q
03/31/2022
7.95%
7Q
12/31/2021
83.46%
8Q
03/31/2021
71.55%
11Q
12/31/2020
71.64%
12Q
09/30/2020
73.09%
13Q
06/30/2020
72.57%
14Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR JOURNEY MEDICAL CORP
LOADING...